Vilin Bio Med Ltd.

View in App
21.60 +0.05 ▲0.2%

29 September 2023, 03:52:10 PM
Volume: 8,000

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.vilinbiomed.co.in
Market Cap 30.13 Cr.
Enterprise Value(EV) 35.06 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) 0.89 Trailing Twelve Months Ending 2023-03
Price-Earning Ratio (PE) 24.20 Trailing Twelve Months Ending 2023-03
Industry PE 38.47 Trailing Twelve Months Ending 2023-03
Book Value / Share 19.65 Trailing Twelve Months Ending 2023-03
Price to Book Value 1.10 Calculated using Price: 21.60
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 1.40 Cr. 13,950,000 Shares
FaceValue 10
About Vilin Bio Med Ltd.
The company is engaged in the manufacturing of pharmaceuticals formulations such as Oral Liquids, Dry syrups, Sachets, External Preparations, Beta and Non Beta Lactam tablets and Capsules & Nutritional Food supplements.

Vilin Bio Med Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Vilin Bio Med Ltd. Performance

View details >>
1 Day
+0.23%
1 Week
-1.82%
1 Month
-8.09%
3 Month
6 Month
1 Year
2 Year
5 Year
10 Year

Vilin Bio Med Ltd. Fundamental Ratios

View details >>
3 years 2020-03 2021-03 2022-03
Return on Equity (%) 2.24 1.66 0.45
Return on Capital Employed (%) 5.09 4.89 4.31
Return on Assets (%) 1.16 0.87 0.24

Vilin Bio Med Ltd. Balance Sheet

View details >>
Particulars 4 years 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03* Rs. Cr.
Shh. Funds 7 7 7 11
Non Curr. Liab. 0 1 1 1
Curr. Liab. 7 5 5 7
Minority Int.
Equity & Liab. 14 14 14 18
Non Curr. Assets 2 2 2 4
Curr. Assets 12 12 12 13
Misc. Exp. not W/O
Total Assets 14 14 14 18

Vilin Bio Med Ltd. Profit and Loss

View details >>
Particulars 3 years 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Net Sales 17 12 11
Other Income 0 0
Total Income 17 12 11
Total Expenditure -16 -11 -10
PBIDT 1 1 1
Interest 0 0 -1
Depreciation 0 0 0
Taxation 0 0 0
Exceptional Items
PAT 0 0 0
Adjusted EPS 0 0 0

Vilin Bio Med Ltd. Cash Flow

View details >>
Particulars 3 years 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. -1 -1 0
Cash Fr. Inv. 0
Cash Fr. Finan. 2 1 0
Net Change 0 0 0
Cash & Cash Eqvt 0 0 0

Vilin Bio Med Ltd. Shareholding Pattern

View details >>

No shareholding pattern found.

Vilin Bio Med Ltd. Announcements

View details >>

No Corporate Announcement found.

Vilin Bio Med Ltd. Technical Scans

View details >>
Fri, 29 Sep 2023
Opening at Low Opening at Low
Closing Above Previous High Closing Above Previous High
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
Close Below Last Week Low Close Below Last Week Low
High Decrease in 1 Month High Decrease in 1 Month

Vilin Bio Med Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 278,106.92 1,159.10 +2.4%
Divi's Laboratories Ltd. 99,942.28 3,761.95 +2.7%
Cipla Ltd. 95,812.44 1,189.75 +2.2%
Dr. Reddy's Laboratories Ltd. 93,178.48 5,595.35 +3.1%
Apollo Hospitals Enterprise Ltd. 73,867.93 5,149.95 +2.5%
Mankind Pharma Ltd. 71,831.52 1,793.15 +1.6%
Torrent Pharmaceuticals Ltd. 65,264.13 1,928.35 +3.4%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 32.97 1,159.10 +2.4%
Divi's Laboratories Ltd. Consolidated 2023-06 67.60 3,761.95 +2.7%
Cipla Ltd. Consolidated 2023-06 30.87 1,189.75 +2.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 19.76 5,595.35 +3.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 110.76 5,149.95 +2.5%
Mankind Pharma Ltd. Consolidated 2023-03 56.04 1,793.15 +1.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 51.80 1,928.35 +3.4%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 4.79 1,159.10 +2.4%
Divi's Laboratories Ltd. Consolidated 2023-06 7.61 3,761.95 +2.7%
Cipla Ltd. Consolidated 2023-06 3.95 1,189.75 +2.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 3.80 5,595.35 +3.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 11.81 5,149.95 +2.5%
Mankind Pharma Ltd. Consolidated 2023-03 5.87 1,793.15 +1.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 9.92 1,928.35 +3.4%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,159.10 +2.4%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,761.95 +2.7%
Cipla Ltd. Consolidated 2023-03 0.02 1,189.75 +2.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,595.35 +3.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,149.95 +2.5%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,793.15 +1.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 1,928.35 +3.4%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,159.10 +2.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,761.95 +2.7%
Cipla Ltd. Consolidated 2023-03 12.85 1,189.75 +2.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,595.35 +3.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,149.95 +2.5%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,793.15 +1.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,928.35 +3.4%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,159.10 +2.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,761.95 +2.7%
Cipla Ltd. Consolidated 2023-03 12.85 1,189.75 +2.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,595.35 +3.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,149.95 +2.5%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,793.15 +1.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,928.35 +3.4%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,159.10 +2.4%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,761.95 +2.7%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,189.75 +2.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,595.35 +3.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,149.95 +2.5%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,793.15 +1.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 1,928.35 +3.4%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,159.10 +2.4%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,761.95 +2.7%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,189.75 +2.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,595.35 +3.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,149.95 +2.5%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,793.15 +1.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 1,928.35 +3.4%

Vilin Bio Med Ltd. FAQ's

What is Vilin Bio Med share price?
Can I buy Vilin Bio Med shares now?
What is the Market Cap of Vilin Bio Med?
What are the key metrics to analyse Vilin Bio Med?
What is the 52 Week High and Low of Vilin Bio Med?
What is the trend of Vilin Bio Med share price?